News Details

( As on 01/07/2025 16:21)

Glenmark Pharma - Intimation Under Regulation 30 (5) Of The Securities And Exchange Board Of India (Listing Obligations And D

Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, details of Key Managerial Personnel of the Company who are severally authorised for determining materiality of an event or information and for the purpose of making disclosures to stock exchanges is attached.